ENTREMED INC | 1,545 Euro | +0,019 +1,25 % | |
| WKN: A1C07N ISIN: US29382F2020 Ticker-Symbol: ENMN | Frankfurt | 25.05.12 | 18:15 Uhr |
Branche BiotechnologieAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten | Leser | Medien | |
|---|---|---|---|---|
| 15.05. | EntreMed Reports First Quarter 2012 Financial Results | 5 | PR Newswire | |
| ROCKVILLE, Md., May 15, 2012 /PRNewswire/ --EntreMed, Inc. (NASDAQ: ENMD), a clinical-stage pharmaceutical company, today reported financial results for the three months ended March 31, 2012.
(Logo:... Mehr lesen zu: EntreMed Reports First Quarter 2012 Financial Results | ||||
| 10.05. | EntreMed Regains Nasdaq Compliance With Shareholders' Equity Listing Requirement | 13 | PR Newswire | |
| ROCKVILLE, Md., May 10, 2012 /PRNewswire/ --EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has... Mehr lesen zu: EntreMed Regains Nasdaq Compliance With Shareholders' Equity Listing Requirement | ||||
| 03.04. | Dr Ken Ren Appointed As Interim CEO Of EntreMed | 47 | AFX News | |
| WASHINGTON (dpa-AFX) - Clinical-stage pharmaceutical company EntreMed Inc
(ENMD) Tuesday announced that Dr Ken K Ren has been appointed as the Interim
Chief Executive Officer of the company... Mehr lesen zu: Dr Ken Ren Appointed As Interim CEO Of EntreMed | ||||
| 03.04. | EntreMed Appoints Interim CEO | 18 | PR Newswire | |
| ROCKVILLE, Md., April 3, 2012 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that the Company... Mehr lesen zu: EntreMed Appoints Interim CEO | ||||
| 09.03. | ENTREMED INC - 10-K, Annual Report | 2 | SEC Filings | |
| 09.03. | EntreMed Reports Fourth Quarter and Year-End 2011 Financial Results | 24 | PR Newswire | |
| ROCKVILLE, Md., March 9, 2012 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today reported results for... Mehr lesen zu: EntreMed Reports Fourth Quarter and Year-End 2011 Financial Results | ||||
| 05.03. | EntreMed Initiates Plans for China Office | 23 | PR Newswire | |
| ROCKVILLE, Md., March 5, 2012 /PRNewswire/ --EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has... Mehr lesen zu: EntreMed Initiates Plans for China Office | ||||
| 06.02. | EntreMed (ENMD) Enters $9.3M of Strategic Financing, Two Board Members Resign | 3 | StreetInsider.com | |
| 06.02. | EntreMed Completes Strategic Financing | 12 | PR Newswire | |
| ROCKVILLE, Md., Feb. 6, 2012 /PRNewswire/ --EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today... Mehr lesen zu: EntreMed Completes Strategic Financing | ||||
| 06.02. | Biotech Leaders Wei-Wu He, Ph.D and Tak W. Mak, Ph.D Join EntreMed's Board of Directors | 9 | PR Newswire | |
| ROCKVILLE, Md., Feb. 6, 2012 /PRNewswire/ --EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that Wei-Wu... Mehr lesen zu: Biotech Leaders Wei-Wu He, Ph.D and Tak W. Mak, Ph.D Join EntreMed's Board of Directors | ||||
| 23.01. | EntreMed (ENMD) Enters $10M in Purchase Agreements; Will Issue Convertible Notes | 4 | StreetInsider.com | |
| 23.01. | EntreMed Secures $10 Million Strategic Financing | 22 | PR Newswire | |
| ROCKVILLE, Md., Jan. 23, 2012 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has... Mehr lesen zu: EntreMed Secures $10 Million Strategic Financing | ||||
Startseite • Nachrichten • Aktienkurse • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Chartanalysen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
